Development of Antibody‐Directed Therapies: Quo Vadis?

Publisher： John Wiley & Sons Inc

E-ISSN： 1521-3773|57|8|2032-2034

ISSN： 1433-7851

Source： ANGEWANDTE CHEMIE INTERNATIONAL EDITION, Vol.57, Iss.8, 2018-02, pp. : 2032-2034

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Innovationsstandort Deutschland – Quo Vadis?

By  

BETON- UND STAHLBETONBAU, Vol. 110, Iss. 4, 2015-04 ,pp. : 243-243

John Wiley & Sons Inc

Access to resources Recommend Favorite

Antikörpergerichtete Therapien: Quo vadis?

By  

ANGEWANDTE CHEMIE, Vol. 130, Iss. 8, 2018-02 ,pp. : 2050-2052

John Wiley & Sons Inc

Access to resources Recommend Favorite

Editorial: Quo vadis, cold molecules?

By Doyle J.   Friedrich B.   Krems R.   Masnou-Seeuws F.  

The European Physical Journal D - Atomic, Molecular and Optical Physics, Vol. 31, Iss. 2, 2004-11 ,pp. : 149-164

Springer Publishing Company

Access to resources Recommend Favorite

Block Copolymer Self‐Assembly in Solution—Quo Vadis?

By  

CHEMISTRY - AN ASIAN JOURNAL, Vol. 13, Iss. 3, 2018-02 ,pp. : 230-239

John Wiley & Sons Inc

Access to resources Recommend Favorite

Technologie und Einsatz von chemischen Sensoren/Biosensoren: Quo vadis? Technologie und Einsatz von chemischen Sensoren/Biosensoren: Quo vadis?

By Simon Wilhelm  

CHIMIA International Journal for Chemistry, Vol. 44, Iss. 12, 1990-12 ,pp. : 395-396

Swiss Chemical Society

Access to resources Recommend Favorite